Shares of Bionano Genomics dropped by a staggering 25.93% in 30 days from $-20.03 to $5.90 at 10:36 EST on Tuesday, after three successive sessions in a row of losses. NASDAQ Composite is falling 0.18% to $13,889.38, following last session’s downward trend, This seems, so far, a somewhat rough trend trading session today.
Bionano Genomics’s last close was $5.66, 165.93% below its 52-week high of $15.69.
Bionano Genomics’s Sales
Bionano Genomics’s sales growth is 160.5% for the current quarter and 203.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 86.7% and 44.4%, respectively.
Bionano Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 43%, now sitting on 8.5M for the twelve trailing months.
Bionano Genomics’s Stock Yearly Top and Bottom Value
Bionano Genomics’s stock is valued at $5.90 at 10:36 EST, way below its 52-week high of $15.69 and way above its 52-week low of $0.28.
Bionano Genomics’s Moving Average
Bionano Genomics’s worth is way under its 50-day moving average of $9.47 and way higher than its 200-day moving average of $4.64.
More news about Bionano Genomics.